Lancellotti P, Petitjean H, Postolache A, et al.Focus on valvular heart disease. Acta Cardiol. 2022;77(10):861–863. doi: 10.1080/00015385.2022.2159193.
Viva T, Sperlongano S, Trung MN, et al.Staging cardiac damage in aortic stenosis: stratifying prognosis to individualise the treatment. Acta Cardiol. 2025;25:1–4.
Lancellotti P, Piette C., Special issue on atrial fibrillation. Acta Cardiol. 2023;78(3):269–273. doi: 10.1080/00015385.2023.2205277.
Martens B, Duytschaever M., Early rhythm control in atrial fibrillation anno 2024. Acta Cardiol. 2024;79(10):1064–1070. doi: 10.1080/00015385.2024.2324217.
Mairesse GH, De Sutter J, Lancellotti P, et al.Summary of 2021 ESC Guidelines on cardiac pacing and cardiac resynchronisation therapy, on cardiovascular disease prevention, on the management of valvular heart disease and of heart failure. Acta Cardiol. 2025;26:1–8. doi: 10.1080/00015385.2025.2506338.
Liu B, Wang Y, Liu Y, et al.Effects of percutaneous balloon mitral valvuloplasty in patients with mitral stenosis and atrial fibrillation: a systematic review and meta-analysis. Acta Cardiol. 2022;77(10):890–899. doi: 10.1080/00015385.2021.1989837.
Dogheim GM, Amralla MT, Werida RH., The clinical significance of neopterin and NT-pro BNP in chronic heart failure: a systematic review. Acta Cardiol. 2024;79(6):720–729. doi: 10.1080/00015385.2024.2371628.
Zuin M, Rigatelli G, Bilato C., Weekend atrial fibrillation hospitalizations are associated with higher short-term mortality. Acta Cardiol. 2023;78(9):1006–1011. doi: 10.1080/00015385.2023.2223007.
Karakasis P, Lefkou E, Patoulias D, et al.Clonal haematopoiesis of indeterminate potential and risk of atrial fibrillation. Acta Cardiol. 2025;25:1–2. doi: 10.1080/00015385.2025.2471655.
Anagnostopoulos I, Kousta M, Kossyvakis C, et al.The role of left atrial peak systolic strain in atrial fibrillation recurrence after catheter ablation. A systematic review and meta-analysis. Acta Cardiol. 2022;77(6):536–544. doi: 10.1080/00015385.2021.1965747.
Beneki E, Rapis K, Zisimos K, et al.Right atrium pressure estimation in tricuspid regurgitation: watch the “rainbow” of echocardiographic parameters. Acta Cardiol. 2024;16:1–4. doi: 10.1080/00015385.2024.2436812.
Bayram Z, Dogan C, Efe SC, et al.Ischaemic versus non-ischaemic: how does heart failure aetiology affect pulmonary arterial capacitance and pulmonary artery pulsatility index in end-stage heart failure?Acta Cardiol. 2022;77(3):204–210. doi: 10.1080/00015385.2021.1951999.
Zhao D, Bai J., Valvular heart disease and heart-related disease: a bibliometric and visual analysis from 2000 to 2023. Acta Cardiol. 2025;28:1–12. doi: 10.1080/00015385.2025.2450983.
Rogiers M, Jentjens S, Guler I, et al.Value of (18)F-FDG pet/CT for prognostic assessment in patients with infective endocarditis. Acta Cardiol. 2022;77(10):900–909. doi: 10.1080/00015385.2022.2040823.
Lancellotti P, Go YY., The power of negative metabolic imaging: negative FDG-PET/CT predicts infective endocarditis resolution. Eur Heart J Cardiovasc Imaging. 2023;24(11):1489–1490. doi: 10.1093/ehjci/jead175.
Suwa Y, Miyasaka Y, Taniguchi N, et al.Predictors of in-hospital mortality in patients with infective endocarditis. Acta Cardiol. 2021;76(6):642–649. doi: 10.1080/00015385.2020.1767368.
Sadeghpour A, Maleki M, Boodagh S, et al.Impact of the Iranian Registry of Infective Endocarditis (IRIE) and multidisciplinary team approach on patient management. Acta Cardiol. 2021;76(8):838–841. doi: 10.1080/00015385.2020.1781423.
Altunova M, Evsen A, Zencirkiran Agus H, et al.Predicting in-hospital mortality in infective endocarditis: insights from the Naples prognostic score. Acta Cardiol. 2025;80(3):292–301. doi: 10.1080/00015385.2025.2491150.
Vural Ö, Yılmaz Ö, Gedikli Ö, et al.Aetiology, clinical characteristics, and risk factors influencing mortality in patients with infective endocarditis: a retrospective study. Acta Cardiol. 2025;3:1–8. doi: 10.1080/00015385.2025.2511519.
Erba PA, Pizzi MN, Roque A, et al.Multimodality Imaging in Infective Endocarditis: an Imaging Team Within the Endocarditis Team. Circulation. 2019;140(21):1753–1765. doi: 10.1161/CIRCULATIONAHA.119.040228.
Esmaely F, Moradnejad P, Boudagh S, et al.Radiomics and machine learning for predicting valve vegetation in infective endocarditis: a comparative analysis of mitral and aortic valves using TEE imaging. Acta Cardiol. 2025;12:1–18. doi: 10.1080/00015385.2025.2500887.
Pant BP, Walse R, Sivadasapillai H, et al.Left atrial strain as a surrogate parameter for successful percutaneous ballon mitral valvotomy?Acta Cardiol. 2025;80(3):274–282. doi: 10.1080/00015385.2025.2484506.
Rao MS, Reddy SK, Lalani K, et al.Effect of successful percutaneous balloon mitral valvotomy on aortic elastic properties in mitral stenosis. Acta Cardiol. 2025:1–7. doi: 10.1080/00015385.2025.2493975.
Reskovic Luksic V, Separovic Hanzevacki J, Trung MN, et al.The burden and challenges of managing aortic stenosis. Acta Cardiol. 2024;79(1):98–100. doi: 10.1080/00015385.2023.2286690.
Kammoun I, Sghaier A, Bennour E, et al.Current and new imaging techniques in risk stratification of asymptomatic severe aortic stenosis. Acta Cardiol. 2022;77(4):288–296. doi: 10.1080/00015385.2021.1939513.
Galloo X, Lochy S, Unger P., Low-gradient normal-flow aortic stenosis: don’t forget the assessment of the flow rate. Acta Cardiol. 2025;19:1–5. doi: 10.1080/00015385.2025.2503023.
Park DY, An S, Kassab K, et al.Chronological comparison of TAVI and SAVR stratified to surgical risk: a systematic review, meta-analysis, and meta-regression. Acta Cardiol. 2023;78(7):778–789. doi: 10.1080/00015385.2023.2218025.
Deveci OS, Okutucu S, Fatihoglu SG, et al.Cerebral embolic protection devices during transcatheter aortic valve implantation, the current state of the art. Acta Cardiol. 2022;77(3):196–203. doi: 10.1080/00015385.2021.1909276.
Van de Velde-Van De Ginste S, Perkisas S, Vermeersch P, et al.Physical components of frailty in predicting mortality after transcatheter aortic valve implantation (TAVI). Acta Cardiol. 2021;76(7):681–688. doi: 10.1080/00015385.2020.1769346.
De Paepe J, Lamberigts M, Meuris B, et al.Transcatheter aortic valve implantation versus sutureless aortic valve replacement: a single-centre cost analysis. Acta Cardiol. 2024;79(1):30–40. doi: 10.1080/00015385.2023.2268441.
Lancellotti P, Fattouch K, Modine T., Is transcatheter aortic valve implantation for aortic stenosis cost-effective?Acta Cardiol. 2024;79(1):95–97. doi: 10.1080/00015385.2023.2281110.
Dubois C, Adriaenssens T, Annemans L, et al.Transcatheter aortic valve implantation versus surgical aortic valve replacement in severe aortic stenosis patients at low surgical mortality risk: a cost-effectiveness analysis in Belgium. Acta Cardiol. 2024;79(1):46–57. doi: 10.1080/00015385.2023.2282283.
Moscarelli M, Zaccone G, Zlahoda-Huzior A, et al.Valvular and perivalvular thrombosis following self-expandable aortic valve replacement: analysis of 100 multi-detector computed tomography scans. Eur Heart J Open. 2024;4(5):oeae085. doi: 10.1093/ehjopen/oeae085.
Nguyen Trung ML, Postolache A, Petitjean H, et al.Haemostatic changes and outcomes in transcatheter aortic valve implantation. Acta Cardiol. 2025;23:1–12. doi: 10.1080/00015385.2025.2491157.
Wu J, Hou Q, Han Q, et al.Atrial fibrillation is an independent risk factor for new-onset myocardial infarction: a prospective study. Acta Cardiol. 2023;78(3):341–348. doi: 10.1080/00015385.2022.2129184.
Zhang K, Ma Z, Yang Y, et al.Beneficial effects of doxycycline on atrial electrical remodelling in a rat model of atrial fibrillation. Acta Cardiol. 2025;8:1–11. doi: 10.1080/00015385.2025.2500888.
Ozaki Y, Uemura Y, Kondo T, et al.Clinical impact of pulmonary artery pulsatility index in patients with atrial fibrillation and heart failure. Acta Cardiol. 2025;30:1–9. doi: 10.1080/00015385.2025.2510705.
Chen Y, Zhou H, Wu L, et al.Conventional versus modified superior vena cava ablation for atrial fibrillation: efficiency and recurrent burden. Acta Cardiol. 2025;17:1–10. doi: 10.1080/00015385.2025.2516945.
Sun H, Zhu RY, Hu HT, et al.Assessment of left atrial mechanical dispersion by real-time 3D echocardiography combined with DR-FLASH score for predicting late recurrence after ablation in paroxysmal atrial fibrillation. Acta Cardiol. 2025;11:1–10. doi: 10.1080/00015385.2025.2516944.
Vandenberk B, Ferrick N, Wan EY, et al.International survey of cardiac device clinic staff determining patient-perceived challenges with remote monitoring. Acta Cardiol. 2025;29:1–10.
Demesmaker V, De Brabandere K, Born B, et al.Infectious pseudoaneurysm of the apex of the left cardiac ventricle in a drug addict patient: report of a case. Acta Cardiol. 2025;15:1–3. doi: 10.1080/00015385.2025.2496565.
Doyen B., Persistent atrial thrombus after replace the mitral valve with a bioprosthesis anchored via a transapical approach. Acta Cardiol. 2025;13:1–4. doi: 10.1080/00015385.2025.2462439.
Zekhnini I, Mansour S, Nguyen T., Use of the octaspline multielectrode catheter in a patient with a mechanical mitral valve. Acta Cardiol. 2025;29:1–2. doi: 10.1080/00015385.2025.2496851.
De Pryck O, Derthoo D, Cornelis K, et al.Ischaemic stroke due to thrombus formation on the ventricular side of the mitral valve more than one year after MitraClip implantation: a case report. Acta Cardiol. 2025;6:1–4. doi: 10.1080/00015385.2024.2448868.
De Roy L, Dechaux D, Feller N, et al.A regularly irregular rhythm: how to explain it?Acta Cardiol. 2024;15:1–5. doi: 10.1080/00015385.2024.2391137.
Wang J, Hu P, Wang YH, et al.Recognition and Management of Occult Esophageal Perforation Following Radiofrequency Ablation. Acta Cardiol. 2024;29:1–2. doi: 10.1080/00015385.2024.2396753.
Castillo-Rodriguez C, Salguero-Lopez DA, Swaminath D., Silent threat: navigating subacute cardiac tamponade following atrial fibrillation ablation. Acta Cardiol. 2025;28:1–2. doi: 10.1080/00015385.2025.2493973.
Matta MG, Raniga D, Hefford B, et al.When closure isn’t closure: postoperative dehiscence of surgically ligated left atrial appendage. Acta Cardiol. 2025;30:1. doi: 10.1080/00015385.2025.2510015.
